These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacological modulation of sphingolipids and role in disease and cancer cell biology. Morales A; Fernandez-Checa JC Mini Rev Med Chem; 2007 Apr; 7(4):371-82. PubMed ID: 17430223 [TBL] [Abstract][Full Text] [Related]
8. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era. Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic applications of bioactive sphingolipids in hematological malignancies. Ekiz HA; Baran Y Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271 [TBL] [Abstract][Full Text] [Related]
10. Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology. Geilen CC; Barz S; Bektas M Skin Pharmacol Appl Skin Physiol; 2001; 14(5):261-71. PubMed ID: 11586067 [TBL] [Abstract][Full Text] [Related]
11. Sphingolipids as Regulators of Autophagy and Endocytic Trafficking. Young MM; Wang HG Adv Cancer Res; 2018; 140():27-60. PubMed ID: 30060813 [TBL] [Abstract][Full Text] [Related]
12. Ceramide and other sphingolipids in cellular responses. Yang J; Yu Y; Sun S; Duerksen-Hughes PJ Cell Biochem Biophys; 2004; 40(3):323-50. PubMed ID: 15211031 [TBL] [Abstract][Full Text] [Related]
13. [Sphingolipid and apoptosis]. Wang J; Hu XS; Shi JP Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466 [TBL] [Abstract][Full Text] [Related]
14. Sphingolipid metabolism enzymes as targets for anticancer therapy. Kok JW; Sietsma H Curr Drug Targets; 2004 May; 5(4):375-82. PubMed ID: 15134220 [TBL] [Abstract][Full Text] [Related]
15. Sphingolipid players in the leukemia arena. Ricci C; Onida F; Ghidoni R Biochim Biophys Acta; 2006 Dec; 1758(12):2121-32. PubMed ID: 16904628 [TBL] [Abstract][Full Text] [Related]
18. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Hakomori S Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075 [TBL] [Abstract][Full Text] [Related]
19. Sphingolipids in apoptosis, survival and regeneration in the nervous system. Posse de Chaves EI Biochim Biophys Acta; 2006 Dec; 1758(12):1995-2015. PubMed ID: 17084809 [TBL] [Abstract][Full Text] [Related]